Meeder Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.39K | Buy |
27
+3
| +13% | +$377 | ﹤0.01% | 762 |
|
|
2025
Q1 | $2.65K | Sell |
24
-17
| -41% | -$1.88K | ﹤0.01% | 848 |
|
|
2024
Q4 | $5.6K | Buy |
41
+1
| +3% | +$137 | ﹤0.01% | 819 |
|
|
2024
Q3 | $4.61K | Sell |
40
-8
| -17% | -$922 | ﹤0.01% | 757 |
|
|
2024
Q2 | $6.61K | Hold |
48
| – | – | ﹤0.01% | 732 |
|
|
2024
Q1 | $6.62K | Buy |
+48
| New | +$6.62K | ﹤0.01% | 607 |
|
|
2023
Q2 | – | Sell |
-100
| Closed | -$10.1K | – | 573 |
|
|
2023
Q1 | $10.1K | Sell |
100
-1,127
| -92% | -$114K | ﹤0.01% | 500 |
|
|
2022
Q4 | $147K | Sell |
1,227
-3,199
| -72% | -$382K | 0.01% | 445 |
|
|
2022
Q3 | $469K | Buy |
4,426
+4,253
| +2,458% | +$451K | 0.03% | 397 |
|
|
2022
Q2 | $17K | Sell |
173
-32
| -16% | -$3.15K | ﹤0.01% | 1195 |
|
|
2022
Q1 | $19K | Buy |
+205
| New | +$19K | ﹤0.01% | 1299 |
|
|
2021
Q4 | – | Sell |
-504
| Closed | -$48K | – | 1916 |
|
|
2021
Q3 | $48K | Buy |
504
+414
| +460% | +$39.4K | ﹤0.01% | 1108 |
|
|
2021
Q2 | $9K | Sell |
90
-5,014
| -98% | -$501K | ﹤0.01% | 1734 |
|
|
2021
Q1 | $496K | Buy |
5,104
+5,083
| +24,205% | +$494K | 0.03% | 481 |
|
|
2020
Q4 | $2K | Sell |
21
-8,489
| -100% | -$808K | ﹤0.01% | 1508 |
|
|
2020
Q3 | $818K | Sell |
8,510
-638
| -7% | -$61.3K | 0.05% | 269 |
|
|
2020
Q2 | $1.12M | Sell |
9,148
-1,000
| -10% | -$122K | 0.07% | 231 |
|
|
2020
Q1 | $878K | Buy |
10,148
+4,106
| +68% | +$355K | 0.07% | 230 |
|
|
2019
Q4 | $650K | Buy |
6,042
+1,130
| +23% | +$122K | 0.04% | 355 |
|
|
2019
Q3 | $441K | Buy |
4,912
+4,903
| +54,478% | +$440K | 0.03% | 426 |
|
|
2019
Q2 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 1962 |
|
|
2019
Q1 | – | Sell |
-5,991
| Closed | -$427K | – | 1799 |
|
|
2018
Q4 | $427K | Buy |
5,991
+4,919
| +459% | +$351K | 0.04% | 356 |
|
|
2018
Q3 | $131K | Sell |
1,072
-51
| -5% | -$6.23K | 0.01% | 586 |
|
|
2018
Q2 | $110K | Buy |
1,123
+972
| +644% | +$95.5K | 0.01% | 611 |
|
|
2018
Q1 | $13K | Buy |
151
+19
| +14% | +$1.64K | ﹤0.01% | 1001 |
|
|
2017
Q4 | $10K | Buy |
132
+57
| +76% | +$4.32K | ﹤0.01% | 1127 |
|
|
2017
Q3 | $5K | Sell |
75
-62
| -45% | -$4.13K | ﹤0.01% | 1269 |
|
|
2017
Q2 | $6K | Buy |
+137
| New | +$6K | ﹤0.01% | 1148 |
|
|
2016
Q4 | – | Sell |
-1,137
| Closed | -$57K | – | 1021 |
|
|
2016
Q3 | $57K | Buy |
1,137
+983
| +638% | +$49.3K | ﹤0.01% | 639 |
|
|
2016
Q2 | $7K | Sell |
154
-3,700
| -96% | -$168K | ﹤0.01% | 841 |
|
|
2016
Q1 | $152K | Sell |
3,854
-20,787
| -84% | -$820K | 0.01% | 630 |
|
|
2015
Q4 | $1.39M | Buy |
+24,641
| New | +$1.39M | 0.13% | 155 |
|
|
2015
Q3 | – | Sell |
-55,665
| Closed | -$2.66M | – | 720 |
|
|
2015
Q2 | $2.66M | Buy |
+55,665
| New | +$2.66M | 0.27% | 90 |
|